Primary cutaneous Cryptococcus in nonimmunocompromised patients.
Cutaneous cryptococcosis in the nonimmunocompromised host is a rare entity and, when it does occur, presents with protean manifestations making a clinical diagnosis difficult. The diagnosis is made by a combination of a high degree of suspicion, clinical features, and histopathologic examination of the skin biopsy. Antifungals should be used early in the disease; however, the class of antifungal, dose, and duration of therapy is controversial at this time.
Antony
S A
SA
Department of Pediatrics, University of Illinois, Chicago, USA.
Antony
S J
SJ
D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D003453:Cryptococcosis / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D003881:Dermatomycoses / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D003937:Diagnosis, Differential; D006801:Humans; D007121:Immunocompetence; D008297:Male
D000935:Antifungal Agents